| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.67e-05 | 25 | 125 | 4 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 2.30e-05 | 27 | 125 | 4 | GO:0008139 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | FLNA DLG5 SPATA31A3 CALD1 ANK3 MAP1B SPATA31A7 KIF4A SHROOM2 FMNL2 SPATA31A5 KIF9 TTLL6 SIPA1L1 KIF4B MICAL3 DLEC1 LIMCH1 KIF13A | 5.29e-05 | 1099 | 125 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | cadherin binding | FLNA CALD1 ANK3 TBC1D2 FMNL2 CEMIP2 MICALL1 EPS15L1 TJP1 TJP2 | 5.50e-05 | 339 | 125 | 10 | GO:0045296 |
| GeneOntologyMolecularFunction | actin binding | FLNA SPATA31A3 CALD1 MAP1B SPATA31A7 SHROOM2 FMNL2 SPATA31A5 SIPA1L1 MICAL3 LIMCH1 | 2.14e-04 | 479 | 125 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | signal sequence binding | 2.91e-04 | 51 | 125 | 4 | GO:0005048 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | CPEB2 RANBP2 TBC1D30 RASGRF1 TBC1D2 SH2D3A SRGAP2 SIPA1L1 DENND2C BCAR3 TNS3 | 3.48e-04 | 507 | 125 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | CPEB2 RANBP2 TBC1D30 RASGRF1 TBC1D2 SH2D3A SRGAP2 SIPA1L1 DENND2C BCAR3 TNS3 | 3.48e-04 | 507 | 125 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 5.74e-04 | 6 | 125 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | ribosomal protein S6 kinase activity | 8.00e-04 | 7 | 125 | 2 | GO:0004711 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 9.75e-04 | 70 | 125 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FLNA CALD1 ANK3 TBC1D2 FMNL2 CEMIP2 MICALL1 EPS15L1 TJP1 TJP2 CNTN1 | 1.37e-03 | 599 | 125 | 11 | GO:0050839 |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 3.99e-09 | 63 | 124 | 8 | GO:0033120 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 7.62e-09 | 44 | 124 | 7 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 1.67e-08 | 49 | 124 | 7 | GO:0050685 | |
| GeneOntologyBiologicalProcess | nuclear pore organization | 3.57e-06 | 18 | 124 | 4 | GO:0006999 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 4.55e-06 | 207 | 124 | 9 | GO:0043484 | |
| GeneOntologyBiologicalProcess | protein localization to cell-cell junction | 1.20e-05 | 24 | 124 | 4 | GO:0150105 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.30e-05 | 129 | 124 | 7 | GO:0048024 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic translational elongation | 3.59e-05 | 2 | 124 | 2 | GO:1900248 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 4.82e-05 | 158 | 124 | 7 | GO:0050684 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translational elongation | 1.07e-04 | 3 | 124 | 2 | GO:1900247 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 1.74e-04 | 259 | 124 | 8 | GO:1903313 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.80e-04 | 195 | 124 | 7 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 2.16e-04 | 201 | 124 | 7 | GO:0051170 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 2.37e-04 | 144 | 124 | 6 | GO:0043244 | |
| GeneOntologyBiologicalProcess | mRNA transport | 2.46e-04 | 145 | 124 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | actin filament organization | FLNA WASHC2C CALD1 BCAR1 SHROOM2 WASHC2A ZYX SH3D21 TJP1 MICAL3 LIMCH1 | 2.55e-04 | 509 | 124 | 11 | GO:0007015 |
| GeneOntologyBiologicalProcess | protein localization to organelle | USP36 NUP50 FLNA RANBP2 AHI1 WASHC2C ZMYND8 NUP98 DZIP1 POM121C WASHC2A MICALL1 POM121 MCM9 SPIDR POM121B VPS53 | 2.87e-04 | 1091 | 124 | 17 | GO:0033365 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | FLNA WASHC2C CALD1 PCLO BCAR1 SHROOM2 WASHC2A FMNL2 ZYX SH3D21 TJP1 SIPA1L1 MICAL3 LIMCH1 | 3.39e-04 | 803 | 124 | 14 | GO:0030036 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 3.46e-04 | 100 | 124 | 5 | GO:0043242 | |
| GeneOntologyBiologicalProcess | positive regulation of blood-brain barrier permeability | 3.54e-04 | 5 | 124 | 2 | GO:1905605 | |
| GeneOntologyBiologicalProcess | negative regulation of translational elongation | 3.54e-04 | 5 | 124 | 2 | GO:0045900 | |
| GeneOntologyBiologicalProcess | cytoplasmic translational elongation | 3.54e-04 | 5 | 124 | 2 | GO:0002182 | |
| GeneOntologyBiologicalProcess | actin filament-based process | FLNA WASHC2C CALD1 PCLO SRGAP2 BCAR1 SHROOM2 WASHC2A FMNL2 ZYX SH3D21 TJP1 SIPA1L1 MICAL3 LIMCH1 | 3.82e-04 | 912 | 124 | 15 | GO:0030029 |
| GeneOntologyBiologicalProcess | protein localization to bicellular tight junction | 5.29e-04 | 6 | 124 | 2 | GO:1902396 | |
| GeneOntologyBiologicalProcess | protein localization to adherens junction | 5.29e-04 | 6 | 124 | 2 | GO:0071896 | |
| GeneOntologyBiologicalProcess | regulation of neuron migration | 5.30e-04 | 62 | 124 | 4 | GO:2001222 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 5.68e-04 | 309 | 124 | 8 | GO:1901888 | |
| GeneOntologyBiologicalProcess | nucleus organization | 5.75e-04 | 170 | 124 | 6 | GO:0006997 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport to the plasma membrane | 6.11e-04 | 172 | 124 | 6 | GO:0098876 | |
| GeneOntologyBiologicalProcess | RNA transport | 6.69e-04 | 175 | 124 | 6 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 6.69e-04 | 175 | 124 | 6 | GO:0050657 | |
| GeneOntologyBiologicalProcess | endosomal transport | 7.13e-04 | 320 | 124 | 8 | GO:0016197 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 7.31e-04 | 178 | 124 | 6 | GO:0051236 | |
| GeneOntologyBiologicalProcess | cell junction organization | FLNA DLG5 ANK3 MAP1B PCLO DLGAP4 SLITRK4 ZMYND8 CPEB3 SRGAP2 SHROOM2 TJP1 SIPA1L1 TJP2 LIMCH1 | 7.55e-04 | 974 | 124 | 15 | GO:0034330 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NUP50 FLNA RANBP2 WDR36 EP400 RBMY1A1 SMARCAL1 RBMY1C RBMY1D NUP98 RBMY1B RBMY1E E2F5 ZNF217 POM121C E2F8 CCNT2 POM121 ATXN7 ASXL3 RBMY1F SUGP1 MLLT1 AFF1 POM121B AFF4 RAD9A | 2.37e-08 | 1377 | 123 | 27 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear pore | 2.95e-05 | 101 | 123 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | actin cytoskeleton | FLNA CALD1 INPP5D RGS22 BCAR1 SHROOM2 ZYX KIF9 TJP1 SIPA1L1 LIMCH1 FYB1 TNS3 | 3.55e-05 | 576 | 123 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | apical dendrite | 3.61e-05 | 32 | 123 | 4 | GO:0097440 | |
| GeneOntologyCellularComponent | male germ cell nucleus | 1.55e-04 | 86 | 123 | 5 | GO:0001673 | |
| GeneOntologyCellularComponent | spliceosomal complex | 2.86e-04 | 215 | 123 | 7 | GO:0005681 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CPEB2 FLNA DLG5 SLC4A8 CALD1 MAP1B PCLO DLGAP4 SLITRK4 CPEB3 SRGAP2 PPM1H SIPA1L1 CNTN1 | 3.24e-04 | 817 | 123 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | transcription elongation factor complex | 3.31e-04 | 56 | 123 | 4 | GO:0008023 | |
| GeneOntologyCellularComponent | super elongation complex | 5.07e-04 | 6 | 123 | 2 | GO:0032783 | |
| GeneOntologyCellularComponent | dendrite | FLNA SLC4A8 CALD1 ANK3 MAP1B RASGRF1 PCLO DLGAP4 ZMYND8 CPEB3 SRGAP2 CHRM5 GPR179 SIPA1L1 | 5.28e-04 | 858 | 123 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | FLNA SLC4A8 CALD1 ANK3 MAP1B RASGRF1 PCLO DLGAP4 ZMYND8 CPEB3 SRGAP2 CHRM5 GPR179 SIPA1L1 | 5.40e-04 | 860 | 123 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | germ cell nucleus | 5.50e-04 | 113 | 123 | 5 | GO:0043073 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber | 7.07e-04 | 7 | 123 | 2 | GO:0097457 | |
| GeneOntologyCellularComponent | postsynapse | FLNA DLG5 CALD1 ANK3 MAP1B PCLO DLGAP4 ZMYND8 CPEB3 SRGAP2 CHRM5 GPR179 CHRNB4 SIPA1L1 CNTN1 | 9.48e-04 | 1018 | 123 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.00e-03 | 129 | 123 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.50e-03 | 10 | 123 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | adherens junction | 1.61e-03 | 212 | 123 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | podosome | 1.80e-03 | 41 | 123 | 3 | GO:0002102 | |
| GeneOntologyCellularComponent | microtubule associated complex | 2.65e-03 | 161 | 123 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 2.94e-03 | 503 | 123 | 9 | GO:0099572 | |
| HumanPheno | Abnormal tricuspid chordae tendinae morphology | 3.35e-05 | 2 | 30 | 2 | HP:0031442 | |
| HumanPheno | Short chordae tendineae of the tricuspid valve | 3.35e-05 | 2 | 30 | 2 | HP:0006692 | |
| HumanPheno | Short chordae tendineae of the mitral valve | 3.35e-05 | 2 | 30 | 2 | HP:0011580 | |
| Domain | RBM1CTR | 5.32e-10 | 8 | 119 | 5 | PF08081 | |
| Domain | RBM1CTR | 5.32e-10 | 8 | 119 | 5 | IPR012604 | |
| Domain | SH3 | 1.01e-05 | 216 | 119 | 9 | SM00326 | |
| Domain | SH3 | 1.01e-05 | 216 | 119 | 9 | PS50002 | |
| Domain | SH3_domain | 1.17e-05 | 220 | 119 | 9 | IPR001452 | |
| Domain | FAM21 | 4.03e-05 | 2 | 119 | 2 | IPR027308 | |
| Domain | PNRC1/2 | 4.03e-05 | 2 | 119 | 2 | IPR026780 | |
| Domain | SH2 | 4.56e-05 | 101 | 119 | 6 | PF00017 | |
| Domain | DUF4599 | 5.32e-05 | 12 | 119 | 3 | PF15371 | |
| Domain | DUF4599 | 5.32e-05 | 12 | 119 | 3 | IPR027970 | |
| Domain | SH2 | 7.36e-05 | 110 | 119 | 6 | SM00252 | |
| Domain | SH2 | 7.74e-05 | 111 | 119 | 6 | PS50001 | |
| Domain | SH2 | 8.14e-05 | 112 | 119 | 6 | IPR000980 | |
| Domain | - | 8.14e-05 | 112 | 119 | 6 | 3.30.505.10 | |
| Domain | hSH3 | 1.20e-04 | 3 | 119 | 2 | IPR029294 | |
| Domain | hSH3 | 1.20e-04 | 3 | 119 | 2 | PF14603 | |
| Domain | FAM21/CAPZIP | 1.20e-04 | 3 | 119 | 2 | IPR029341 | |
| Domain | ZO | 1.20e-04 | 3 | 119 | 2 | IPR005417 | |
| Domain | CAP-ZIP_m | 1.20e-04 | 3 | 119 | 2 | PF15255 | |
| Domain | Kinesin_motor_CS | 1.32e-04 | 41 | 119 | 4 | IPR019821 | |
| Domain | Kinesin-like_fam | 1.60e-04 | 43 | 119 | 4 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 1.75e-04 | 44 | 119 | 4 | PS00411 | |
| Domain | - | 1.75e-04 | 44 | 119 | 4 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 1.75e-04 | 44 | 119 | 4 | IPR001752 | |
| Domain | Kinesin | 1.75e-04 | 44 | 119 | 4 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 1.75e-04 | 44 | 119 | 4 | PS50067 | |
| Domain | KISc | 1.75e-04 | 44 | 119 | 4 | SM00129 | |
| Domain | CEBP_ZZ | 2.40e-04 | 4 | 119 | 2 | IPR032296 | |
| Domain | TF_AF4/FMR2 | 2.40e-04 | 4 | 119 | 2 | IPR007797 | |
| Domain | CEBP_ZZ | 2.40e-04 | 4 | 119 | 2 | PF16366 | |
| Domain | RRM_7 | 2.40e-04 | 4 | 119 | 2 | PF16367 | |
| Domain | AF-4 | 2.40e-04 | 4 | 119 | 2 | PF05110 | |
| Domain | RRM_1 | 3.75e-04 | 208 | 119 | 7 | PF00076 | |
| Domain | Na/HCO3_transpt | 3.98e-04 | 5 | 119 | 2 | IPR003024 | |
| Domain | GUANYLATE_KINASE_2 | 4.07e-04 | 23 | 119 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 4.07e-04 | 23 | 119 | 3 | PS00856 | |
| Domain | PDZ | 4.14e-04 | 151 | 119 | 6 | PS50106 | |
| Domain | PDZ | 4.29e-04 | 152 | 119 | 6 | IPR001478 | |
| Domain | RRM | 4.84e-04 | 217 | 119 | 7 | SM00360 | |
| Domain | Guanylate_kin | 5.89e-04 | 26 | 119 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 5.89e-04 | 26 | 119 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 5.89e-04 | 26 | 119 | 3 | IPR008144 | |
| Domain | GuKc | 5.89e-04 | 26 | 119 | 3 | SM00072 | |
| Domain | RRM_dom | 6.32e-04 | 227 | 119 | 7 | IPR000504 | |
| Domain | RRM | 6.83e-04 | 230 | 119 | 7 | PS50102 | |
| Domain | CH | 7.86e-04 | 65 | 119 | 4 | SM00033 | |
| Domain | DUF3585 | 8.28e-04 | 7 | 119 | 2 | IPR022735 | |
| Domain | DUF3585 | 8.28e-04 | 7 | 119 | 2 | PF12130 | |
| Domain | RasGEF | 9.03e-04 | 30 | 119 | 3 | PF00617 | |
| Domain | - | 9.03e-04 | 30 | 119 | 3 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 9.03e-04 | 30 | 119 | 3 | IPR023578 | |
| Domain | RASGEF_cat_dom | 9.03e-04 | 30 | 119 | 3 | IPR001895 | |
| Domain | RasGEF | 9.03e-04 | 30 | 119 | 3 | SM00147 | |
| Domain | LIM | 9.84e-04 | 69 | 119 | 4 | PF00412 | |
| Domain | - | 1.04e-03 | 70 | 119 | 4 | 2.10.110.10 | |
| Domain | CH | 1.04e-03 | 70 | 119 | 4 | PF00307 | |
| Domain | Znf_LIM | 1.10e-03 | 71 | 119 | 4 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 1.10e-03 | 71 | 119 | 4 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 1.10e-03 | 71 | 119 | 4 | PS50023 | |
| Domain | - | 1.10e-03 | 71 | 119 | 4 | 1.10.418.10 | |
| Domain | LIM | 1.10e-03 | 71 | 119 | 4 | SM00132 | |
| Domain | E2F | 1.10e-03 | 8 | 119 | 2 | IPR015633 | |
| Domain | CH | 1.22e-03 | 73 | 119 | 4 | PS50021 | |
| Domain | Nucleotide-bd_a/b_plait | 1.33e-03 | 258 | 119 | 7 | IPR012677 | |
| Domain | CH-domain | 1.34e-03 | 75 | 119 | 4 | IPR001715 | |
| Domain | ZU5 | 1.41e-03 | 9 | 119 | 2 | SM00218 | |
| Domain | Band3_cytoplasmic_dom | 1.41e-03 | 9 | 119 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 1.41e-03 | 9 | 119 | 2 | PF07565 | |
| Domain | - | 1.41e-03 | 9 | 119 | 2 | 3.40.1100.10 | |
| Domain | HCO3_cotransp | 1.75e-03 | 10 | 119 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 1.75e-03 | 10 | 119 | 2 | IPR011531 | |
| Domain | ZU5 | 1.75e-03 | 10 | 119 | 2 | PS51145 | |
| Domain | PTrfase/Anion_transptr | 1.75e-03 | 10 | 119 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.75e-03 | 10 | 119 | 2 | IPR003020 | |
| Domain | PDZ | 2.10e-03 | 141 | 119 | 5 | PF00595 | |
| Domain | EH | 2.13e-03 | 11 | 119 | 2 | PS50031 | |
| Domain | E2F_TDP | 2.13e-03 | 11 | 119 | 2 | PF02319 | |
| Domain | E2F_TDP | 2.13e-03 | 11 | 119 | 2 | SM01372 | |
| Domain | EH | 2.13e-03 | 11 | 119 | 2 | SM00027 | |
| Domain | E2F_WHTH_DNA-bd_dom | 2.13e-03 | 11 | 119 | 2 | IPR003316 | |
| Domain | EH_dom | 2.13e-03 | 11 | 119 | 2 | IPR000261 | |
| Domain | SH3_2 | 2.23e-03 | 86 | 119 | 4 | IPR011511 | |
| Domain | SH3_2 | 2.23e-03 | 86 | 119 | 4 | PF07653 | |
| Domain | Ran_BP1 | 2.55e-03 | 12 | 119 | 2 | PF00638 | |
| Domain | ZU5 | 2.55e-03 | 12 | 119 | 2 | PF00791 | |
| Domain | RANBD1 | 2.55e-03 | 12 | 119 | 2 | PS50196 | |
| Domain | ZU5_dom | 2.55e-03 | 12 | 119 | 2 | IPR000906 | |
| Domain | PDZ | 2.59e-03 | 148 | 119 | 5 | SM00228 | |
| Domain | - | 2.74e-03 | 150 | 119 | 5 | 2.30.42.10 | |
| Domain | RanBD | 3.00e-03 | 13 | 119 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 3.00e-03 | 13 | 119 | 2 | IPR000156 | |
| Domain | Spectrin_alpha_SH3 | 4.00e-03 | 15 | 119 | 2 | IPR013315 | |
| Domain | - | 4.76e-03 | 244 | 119 | 6 | 3.30.70.330 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.84e-07 | 40 | 90 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.15e-07 | 41 | 90 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.49e-07 | 42 | 90 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.88e-07 | 43 | 90 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 4.98e-07 | 47 | 90 | 6 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 6.42e-07 | 49 | 90 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 7.25e-07 | 50 | 90 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 8.18e-07 | 51 | 90 | 6 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.29e-06 | 55 | 90 | 6 | MM14917 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 1.67e-06 | 32 | 90 | 5 | M29579 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.77e-06 | 58 | 90 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.77e-06 | 58 | 90 | 6 | MM14736 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 1.95e-06 | 33 | 90 | 5 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 2.28e-06 | 34 | 90 | 5 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.65e-06 | 35 | 90 | 5 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 3.06e-06 | 36 | 90 | 5 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.06e-06 | 36 | 90 | 5 | M27245 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.49e-06 | 65 | 90 | 6 | MM15147 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 3.52e-06 | 37 | 90 | 5 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 3.52e-06 | 37 | 90 | 5 | M27038 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 4.60e-06 | 39 | 90 | 5 | M27238 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 5.93e-06 | 41 | 90 | 5 | M29574 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 6.91e-06 | 73 | 90 | 6 | MM14948 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 7.54e-06 | 43 | 90 | 5 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 8.46e-06 | 44 | 90 | 5 | M109 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.06e-05 | 46 | 90 | 5 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.18e-05 | 47 | 90 | 5 | M27395 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.36e-05 | 82 | 90 | 6 | MM15394 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 1.50e-05 | 24 | 90 | 4 | MM15658 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.56e-05 | 84 | 90 | 6 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.79e-05 | 86 | 90 | 6 | MM15413 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.14e-05 | 53 | 90 | 5 | M27212 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.34e-05 | 54 | 90 | 5 | M29594 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.63e-05 | 92 | 90 | 6 | MM14951 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 3.62e-05 | 59 | 90 | 5 | M27606 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 3.98e-05 | 99 | 90 | 6 | M27474 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 8.78e-05 | 114 | 90 | 6 | MM15361 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 8.86e-05 | 71 | 90 | 5 | M27394 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 1.08e-04 | 74 | 90 | 5 | M48006 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.30e-04 | 77 | 90 | 5 | M27226 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.76e-04 | 82 | 90 | 5 | M27250 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.97e-04 | 84 | 90 | 5 | M725 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.08e-04 | 85 | 90 | 5 | M1870 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 3.78e-04 | 149 | 90 | 6 | M4076 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 4.06e-04 | 151 | 90 | 6 | M550 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 4.64e-04 | 101 | 90 | 5 | M27253 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 5.79e-04 | 106 | 90 | 5 | M27458 | |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 5.88e-04 | 26 | 90 | 3 | M47439 | |
| Pathway | REACTOME_TRNA_PROCESSING | 7.14e-04 | 111 | 90 | 5 | M27684 | |
| Pathway | REACTOME_SUMOYLATION | 7.36e-04 | 169 | 90 | 6 | MM14919 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | 8.72e-04 | 116 | 90 | 5 | M29806 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 9.26e-04 | 68 | 90 | 4 | MM14921 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 9.37e-04 | 177 | 90 | 6 | M27476 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.05e-03 | 121 | 90 | 5 | M872 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 1.26e-03 | 126 | 90 | 5 | M45009 | |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 1.50e-03 | 131 | 90 | 5 | M5283 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 1.75e-03 | 10 | 90 | 2 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 1.75e-03 | 10 | 90 | 2 | MM15073 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 1.75e-03 | 10 | 90 | 2 | MM14956 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 1.89e-03 | 138 | 90 | 5 | M29805 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 1.94e-03 | 204 | 90 | 6 | M45011 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.95e-03 | 139 | 90 | 5 | M715 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.95e-03 | 277 | 90 | 7 | MM15414 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 2.14e-03 | 11 | 90 | 2 | M48099 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 2.14e-03 | 11 | 90 | 2 | M9990 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 2.14e-03 | 142 | 90 | 5 | M27660 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 3.00e-03 | 299 | 90 | 7 | M41727 | |
| Pathway | REACTOME_INFLUENZA_INFECTION | 3.30e-03 | 157 | 90 | 5 | M4669 | |
| Pathway | REACTOME_HIV_INFECTION | 3.59e-03 | 231 | 90 | 6 | M12469 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.75e-03 | 49 | 90 | 3 | M891 | |
| Pathway | REACTOME_HCMV_INFECTION | 3.78e-03 | 162 | 90 | 5 | M29804 | |
| Pubmed | 1.40e-14 | 7 | 126 | 6 | 8269511 | ||
| Pubmed | 1.82e-12 | 12 | 126 | 6 | 9598316 | ||
| Pubmed | 3.45e-12 | 6 | 126 | 5 | 15184870 | ||
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 1.20e-11 | 7 | 126 | 5 | 8875892 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | USP36 NUP50 FLNA RANBP2 ZNF609 REXO4 SETX WDR36 CALD1 EP400 MAP1B ZMYND8 NUP98 KIF4A NDUFV3 PRAM1 EPS15L1 TJP1 SUGP1 MLLT1 AFF4 | 3.63e-11 | 954 | 126 | 21 | 36373674 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG DLG5 SETX MAP1B SRGAP2 DZIP1 BCAR1 ZYX PPM1H E2F8 C6orf132 MICALL1 KSR1 TJP1 SIPA1L1 NAV1 TJP2 LIMCH1 KIF13A TNS3 | 4.34e-11 | 861 | 126 | 20 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLNA SYNRG RANBP2 WASHC2C EP400 ZMYND8 TBC1D2 NUP98 ZNF217 ZYX MICALL1 CCNT2 EPS15L1 ATXN7 SIPA1L1 TJP2 AFF1 MICAL3 LIMCH1 | 5.50e-11 | 774 | 126 | 19 | 15302935 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | NUP50 FLNA SYNRG RANBP2 ZNF609 SETX WASHC2C CALD1 EP400 MAP1B ZYX EPS15L1 TJP1 ATXN7 SUGP1 | 8.72e-11 | 444 | 126 | 15 | 34795231 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | USP36 NUP50 FLNA SYNRG RANBP2 WDR36 WASHC2C CALD1 EP400 MAP1B ZMYND8 NUP98 KIF4A SRGAP2 POM121C ZYX EPS15L1 TJP1 SUGP1 AFF4 | 1.81e-10 | 934 | 126 | 20 | 33916271 |
| Pubmed | NUP50 FLNA RANBP2 SETX ERF WASHC2C RPS6KA3 NUP98 KIF4A BCAR1 ZYX EPS15L1 TJP2 BCAR3 KIF13A | 4.88e-10 | 503 | 126 | 15 | 16964243 | |
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 8.19e-10 | 5 | 126 | 4 | 8817321 | |
| Pubmed | 8.19e-10 | 5 | 126 | 4 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 8.19e-10 | 5 | 126 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 8.19e-10 | 5 | 126 | 4 | 19737860 | |
| Pubmed | 2.45e-09 | 6 | 126 | 4 | 18239052 | ||
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 2.45e-09 | 6 | 126 | 4 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 2.45e-09 | 6 | 126 | 4 | 12356914 | |
| Pubmed | 2.45e-09 | 6 | 126 | 4 | 9499427 | ||
| Pubmed | 2.45e-09 | 6 | 126 | 4 | 15051956 | ||
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 3.44e-09 | 17 | 126 | 5 | 28115466 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 5.03e-09 | 38 | 126 | 6 | 12791264 | |
| Pubmed | 5.70e-09 | 7 | 126 | 4 | 17001072 | ||
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 5.70e-09 | 7 | 126 | 4 | 10377282 | |
| Pubmed | 1.14e-08 | 8 | 126 | 4 | 7479793 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | FLNA DLG5 CALD1 ANK3 SRGAP2 FMNL2 ZYX CEMIP2 C6orf132 MICALL1 EPS15L1 TJP1 TJP2 LIMCH1 | 1.98e-08 | 565 | 126 | 14 | 25468996 |
| Pubmed | 3.39e-08 | 10 | 126 | 4 | 10601091 | ||
| Pubmed | 3.39e-08 | 10 | 126 | 4 | 9384609 | ||
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 4.64e-08 | 3 | 126 | 3 | 30802453 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 35507432 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ZNF609 ANK3 EP400 INPP5D ZMYND8 NUP98 BCAR1 POM121C SH3D21 C6orf132 POM121 AFF1 | 5.99e-08 | 430 | 126 | 12 | 35044719 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | USP36 FLNA SYNRG RANBP2 ZNF609 REXO4 CALD1 MAP1B SRGAP2 WASHC2A ZYX MICALL1 TJP1 TJP2 TNS3 | 6.29e-08 | 724 | 126 | 15 | 36232890 |
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 7.95e-08 | 12 | 126 | 4 | 20543856 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 1.14e-07 | 13 | 126 | 4 | 23816659 | |
| Pubmed | 1.14e-07 | 13 | 126 | 4 | 10749975 | ||
| Pubmed | USP36 REXO4 SETX WDR36 ERF ANK3 EP400 NUP98 KIF4A FMNL2 CEMIP2 EPS15L1 TJP1 TJP2 CLEC16A | 1.56e-07 | 777 | 126 | 15 | 35844135 | |
| Pubmed | 1.60e-07 | 14 | 126 | 4 | 20854876 | ||
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 1.60e-07 | 14 | 126 | 4 | 14611631 | |
| Pubmed | FLNA SYNRG RANBP2 SLC4A8 WASHC2C ANK3 MAP1B PCLO DLGAP4 SHROOM2 WASHC2A EPS15L1 TJP1 SIPA1L1 NAV1 TJP2 SLC4A4 CLEC16A | 1.64e-07 | 1139 | 126 | 18 | 36417873 | |
| Pubmed | 1.67e-07 | 67 | 126 | 6 | 29254152 | ||
| Pubmed | Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4. | 1.85e-07 | 4 | 126 | 3 | 25282333 | |
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 1.85e-07 | 4 | 126 | 3 | 17900573 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 2.17e-07 | 15 | 126 | 4 | 14762062 | |
| Pubmed | 2.17e-07 | 15 | 126 | 4 | 14697343 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NUP50 ZNF609 AHI1 ERF ANK3 E2F5 SRGAP2 POM121C FMNL2 ZYX PPM1H MICALL1 KSR1 EPS15L1 POM121 SIPA1L1 NAV1 MUC5AC VPS53 | 3.04e-07 | 1321 | 126 | 19 | 27173435 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF704 ZNF609 CALD1 ANK3 MAP1B BLNK SRGAP2 BCAR1 SHROOM2 PPM1H EPS15L1 TJP1 ATXN7 NAV1 AFF1 MICAL3 LIMCH1 SPIDR CLEC16A AFF4 | 4.22e-07 | 1489 | 126 | 20 | 28611215 |
| Pubmed | RANBP2 SLC4A8 ANK3 DLGAP4 KIF4A SRGAP2 PPM1H EPS15L1 TJP1 SIPA1L1 NAV1 KIF4B LIMCH1 SLC4A4 AFF4 CNTN1 | 4.38e-07 | 963 | 126 | 16 | 28671696 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 4.83e-07 | 18 | 126 | 4 | 12023983 | |
| Pubmed | 9.21e-07 | 6 | 126 | 3 | 20850414 | ||
| Pubmed | 9.21e-07 | 6 | 126 | 3 | 10187783 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 9.21e-07 | 6 | 126 | 3 | 25930072 | |
| Pubmed | CPEB2 FLNA CALD1 ANK3 MAP1B PCLO DLGAP4 SRGAP2 SHROOM2 FMNL2 EPS15L1 TJP1 SIPA1L1 NAV1 TJP2 MICAL3 LIMCH1 SLC4A4 CNTN1 | 1.01e-06 | 1431 | 126 | 19 | 37142655 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RANBP2 REXO4 WDR36 INPP5D RPS6KA3 KIF4A SIPA1L1 SUGP1 KIF4B FYB1 | 1.06e-06 | 370 | 126 | 10 | 22922362 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CALD1 MAP1B RPS6KA3 RPS6KB2 BCAR1 ZYX NDUFV3 CCNT2 KSR1 MLLT1 AFF1 BCAR3 SLC4A4 AFF4 TNS3 | 1.14e-06 | 910 | 126 | 15 | 36736316 |
| Pubmed | 1.60e-06 | 222 | 126 | 8 | 37071664 | ||
| Pubmed | The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. | 1.61e-06 | 7 | 126 | 3 | 15856011 | |
| Pubmed | FLNA RANBP2 SETX ANK3 NUP98 POM121C FMNL2 ZYX POM121 NAV1 SLC4A4 | 1.70e-06 | 486 | 126 | 11 | 20936779 | |
| Pubmed | FLNA AHI1 SETX WASHC2C SLC7A13 ANK3 RPS6KA3 SRGAP2 SHROOM2 WASHC2A E2F8 SIPA1L1 TJP2 AFF1 KIF13A AFF4 | 2.05e-06 | 1084 | 126 | 16 | 11544199 | |
| Pubmed | 2.31e-06 | 26 | 126 | 4 | 12228227 | ||
| Pubmed | 2.31e-06 | 26 | 126 | 4 | 35920200 | ||
| Pubmed | NUP50 FLNA RANBP2 ZNF609 SETX EP400 INPP5D ZMYND8 KIF4A ZNF217 ZYX E2F8 CCDC7 CCNT2 PRAM1 SUGP1 | 2.56e-06 | 1103 | 126 | 16 | 34189442 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.59e-06 | 256 | 126 | 8 | 33397691 | |
| Pubmed | 4.74e-06 | 118 | 126 | 6 | 30979931 | ||
| Pubmed | MAP1B RASGRF1 PCLO DLGAP4 SNX17 CPEB3 EPS15L1 SIPA1L1 MICAL3 | 5.22e-06 | 347 | 126 | 9 | 17114649 | |
| Pubmed | FLNA SYNRG CALD1 ANK3 EP400 MAP1B KIF4A ZYX EPS15L1 TJP1 TJP2 | 5.44e-06 | 549 | 126 | 11 | 38280479 | |
| Pubmed | 5.47e-06 | 10 | 126 | 3 | 20153263 | ||
| Pubmed | 5.48e-06 | 121 | 126 | 6 | 22412018 | ||
| Pubmed | 7.50e-06 | 11 | 126 | 3 | 24367103 | ||
| Pubmed | 7.50e-06 | 11 | 126 | 3 | 20471949 | ||
| Pubmed | USP36 DLG5 RANBP2 REXO4 SETX WDR36 TBC1D30 EP400 ZMYND8 KIF4A SRGAP2 ZNF217 C6orf132 ATXN7 SIPA1L1 MLLT1 LIMCH1 AFF4 | 7.87e-06 | 1497 | 126 | 18 | 31527615 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | NUP50 RANBP2 EP400 RPS6KA3 RPS6KB2 CCNT2 SIPA1L1 NAV1 TJP2 MLLT1 AFF1 AFF4 | 9.03e-06 | 695 | 126 | 12 | 23602568 |
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 9.04e-06 | 132 | 126 | 6 | 16944949 | |
| Pubmed | 9.44e-06 | 133 | 126 | 6 | 15144186 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 9.54e-06 | 283 | 126 | 8 | 30585729 | |
| Pubmed | The little elongation complex regulates small nuclear RNA transcription. | 9.97e-06 | 12 | 126 | 3 | 22195968 | |
| Pubmed | Transcriptional and posttranscriptional regulation of HIV-1 gene expression. | 1.29e-05 | 13 | 126 | 3 | 22355797 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.29e-05 | 13 | 126 | 3 | 31427429 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24584939 | ||
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 1.30e-05 | 2 | 126 | 2 | 36482480 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 7542259 | ||
| Pubmed | Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. | 1.30e-05 | 2 | 126 | 2 | 32473614 | |
| Pubmed | The PDZ2 domain of zonula occludens-1 and -2 is a phosphoinositide binding domain. | 1.30e-05 | 2 | 126 | 2 | 19784548 | |
| Pubmed | Whole genome expression microarray reveals novel roles for Kif4 in monocyte/macrophage cells. | 1.30e-05 | 2 | 126 | 2 | 31486502 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 17217619 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 37528066 | ||
| Pubmed | The zonula occludens protein family regulates the hepatic barrier system in the murine liver. | 1.30e-05 | 2 | 126 | 2 | 33184034 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 10773663 | ||
| Pubmed | A Cas-BCAR3 co-regulatory circuit controls lamellipodia dynamics. | 1.30e-05 | 2 | 126 | 2 | 34169835 | |
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 1.30e-05 | 2 | 126 | 2 | 30081192 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 15847701 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 17616674 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 31616463 | ||
| Pubmed | Chromokinesin Kif4 promotes proper anaphase in mouse oocyte meiosis. | 1.30e-05 | 2 | 126 | 2 | 31067151 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 15655368 | ||
| Pubmed | ZO-1- and ZO-2-dependent integration of myosin-2 to epithelial zonula adherens. | 1.30e-05 | 2 | 126 | 2 | 18596233 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 28350061 | ||
| Pubmed | Effects of the differential expression of ZO-1 and ZO-2 on podocyte structure and function. | 1.30e-05 | 2 | 126 | 2 | 29845705 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 10966866 | ||
| Pubmed | TJP1 suppresses trophoblast cell invasion by expressing E2F8 in the human placenta. | 1.30e-05 | 2 | 126 | 2 | 38795825 | |
| Pubmed | Regulation of Tjp1 mRNA by CPEB2 for tight junction assembly in mouse blastocyst. | 1.30e-05 | 2 | 126 | 2 | 35133290 | |
| Pubmed | HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. | 1.30e-05 | 2 | 126 | 2 | 21423673 | |
| Interaction | PFN1 interactions | USP36 SYNRG DLG5 RANBP2 PCLO SRGAP2 FMNL2 C6orf132 TJP1 NAV1 TJP2 MLLT1 MICAL3 LIMCH1 KIF13A AFF4 | 8.54e-08 | 509 | 123 | 16 | int:PFN1 |
| Interaction | SMC5 interactions | USP36 NUP50 FLNA RANBP2 ZNF609 REXO4 SETX WDR36 CALD1 EP400 MAP1B ZMYND8 NUP98 KIF4A BCAR1 NDUFV3 PRAM1 EPS15L1 TJP1 SUGP1 MLLT1 AFF4 | 1.54e-07 | 1000 | 123 | 22 | int:SMC5 |
| Interaction | CGN interactions | 3.94e-07 | 152 | 123 | 9 | int:CGN | |
| Interaction | NAA40 interactions | USP36 NUP50 FLNA SYNRG RANBP2 WDR36 WASHC2C CALD1 EP400 MAP1B ZMYND8 NUP98 KIF4A SRGAP2 POM121C ZYX EPS15L1 TJP1 SUGP1 LIMCH1 AFF4 | 4.57e-07 | 978 | 123 | 21 | int:NAA40 |
| Interaction | YWHAH interactions | SYNRG DLG5 SETX RPS6KA3 RPS6KB2 SRGAP2 DZIP1 BCAR1 PPM1H E2F8 C6orf132 MICALL1 KSR1 TJP1 SIPA1L1 DENND2C NAV1 TJP2 LIMCH1 CLEC16A TNS3 | 3.08e-06 | 1102 | 123 | 21 | int:YWHAH |
| Interaction | YWHAB interactions | SYNRG DLG5 RASGRF1 RPS6KA3 SH2D3A SRGAP2 DZIP1 BCAR1 ZYX PPM1H E2F8 C6orf132 MICALL1 KSR1 TJP1 SIPA1L1 DENND2C NAV1 TJP2 TNS3 | 3.26e-06 | 1014 | 123 | 20 | int:YWHAB |
| Interaction | MAGI1 interactions | 3.36e-06 | 147 | 123 | 8 | int:MAGI1 | |
| Interaction | NUP43 interactions | USP36 NUP50 FLNA RANBP2 ZNF609 REXO4 SETX WDR36 ERF EP400 ZMYND8 NUP98 POM121C CCNT2 POM121 | 6.35e-06 | 625 | 123 | 15 | int:NUP43 |
| Interaction | CD2AP interactions | 6.71e-06 | 214 | 123 | 9 | int:CD2AP | |
| Interaction | LYN interactions | DOK1 DLG5 REXO4 ANK3 INPP5D RPS6KB2 SLITRK4 BLNK DZIP1 BCAR1 FMNL2 CEMIP2 MICALL1 PRAM1 DENND2C MICAL3 | 8.04e-06 | 720 | 123 | 16 | int:LYN |
| Interaction | SIPA1L1 interactions | 1.16e-05 | 174 | 123 | 8 | int:SIPA1L1 | |
| Interaction | VASP interactions | SYNRG WASHC2C DLGAP4 ZYX C6orf132 TJP1 SIPA1L1 TJP2 LIMCH1 FYB1 | 1.32e-05 | 294 | 123 | 10 | int:VASP |
| Interaction | TANC2 interactions | 1.76e-05 | 89 | 123 | 6 | int:TANC2 | |
| Interaction | ELL3 interactions | 1.78e-05 | 26 | 123 | 4 | int:ELL3 | |
| Interaction | ACTR3 interactions | FLNA DLG5 WASHC2C CALD1 WASHC2A TJP1 ASXL3 SIPA1L1 MICAL3 CLEC16A | 1.81e-05 | 305 | 123 | 10 | int:ACTR3 |
| Interaction | AP2B1 interactions | USP36 NUP50 FLNA SYNRG DLG5 FMNL2 EPS15L1 POM121 NAV1 KIF13A AFF4 | 1.82e-05 | 373 | 123 | 11 | int:AP2B1 |
| Interaction | YWHAG interactions | FLNA SYNRG DLG5 RPS6KA3 SH2D3A SRGAP2 DZIP1 BCAR1 SHROOM2 PPM1H E2F8 C6orf132 MICALL1 KSR1 TJP1 SIPA1L1 DENND2C NAV1 TJP2 KIF13A TNS3 | 2.06e-05 | 1248 | 123 | 21 | int:YWHAG |
| Interaction | SOWAHA interactions | 2.08e-05 | 27 | 123 | 4 | int:SOWAHA | |
| Interaction | YWHAE interactions | FLNA SYNRG DLG5 AHI1 CALD1 MAP1B RASGRF1 RBMY1A1 SH2D3A SRGAP2 BCAR1 SHROOM2 ZYX PPM1H E2F8 C6orf132 MICALL1 KSR1 SIPA1L1 NAV1 TJP2 | 2.26e-05 | 1256 | 123 | 21 | int:YWHAE |
| Interaction | TNK2 interactions | 2.65e-05 | 195 | 123 | 8 | int:TNK2 | |
| Interaction | PHLDB2 interactions | 2.80e-05 | 143 | 123 | 7 | int:PHLDB2 | |
| Interaction | FLOT1 interactions | FLNA DLG5 CALD1 ANK3 EP400 PCLO DZIP1 BCAR1 FMNL2 SLC14A1 TJP1 VPS53 | 3.45e-05 | 475 | 123 | 12 | int:FLOT1 |
| Interaction | BCAR1 interactions | INPP5D RPS6KA3 SH2D3A KIF4A BCAR1 ZYX PRAM1 SUGP1 NAV1 BCAR3 KIF13A FYB1 TNS3 | 3.59e-05 | 556 | 123 | 13 | int:BCAR1 |
| Interaction | YWHAQ interactions | FLNA SYNRG DLG5 RPS6KA3 RPS6KB2 SH2D3A SRGAP2 DZIP1 BCAR1 PPM1H E2F8 C6orf132 KSR1 TJP1 SIPA1L1 DENND2C NAV1 TJP2 TNS3 | 4.69e-05 | 1118 | 123 | 19 | int:YWHAQ |
| Interaction | ELL2 interactions | 4.71e-05 | 33 | 123 | 4 | int:ELL2 | |
| Interaction | INPP5E interactions | 4.81e-05 | 65 | 123 | 5 | int:INPP5E | |
| Interaction | PML interactions | NUP50 FLNA SYNRG RANBP2 ZNF609 REXO4 SETX WDR36 WASHC2C CALD1 EP400 MAP1B ZYX EPS15L1 TJP1 ATXN7 SUGP1 | 5.23e-05 | 933 | 123 | 17 | int:PML |
| Interaction | NXF1 interactions | USP36 NUP50 RANBP2 REXO4 WDR36 MAP1B RPS6KB2 DLGAP4 SNX17 SH2D3A NUP98 CPEB3 KIF4A POM121C PPM1H NDUFV3 CCDC7 EPS15L1 POM121 SUGP1 TNS3 | 6.14e-05 | 1345 | 123 | 21 | int:NXF1 |
| Interaction | KCTD3 interactions | 6.69e-05 | 164 | 123 | 7 | int:KCTD3 | |
| Interaction | CDH1 interactions | FLNA DLG5 CALD1 ANK3 SRGAP2 BCAR1 FMNL2 ZYX CEMIP2 C6orf132 MICALL1 EPS15L1 TJP1 TJP2 LIMCH1 | 6.93e-05 | 768 | 123 | 15 | int:CDH1 |
| Interaction | LRFN1 interactions | 1.14e-04 | 124 | 123 | 6 | int:LRFN1 | |
| Interaction | AMOT interactions | 1.28e-04 | 312 | 123 | 9 | int:AMOT | |
| Interaction | NCK1 interactions | 1.28e-04 | 244 | 123 | 8 | int:NCK1 | |
| Interaction | CBY1 interactions | 1.28e-04 | 182 | 123 | 7 | int:CBY1 | |
| Interaction | NADK interactions | 1.30e-04 | 80 | 123 | 5 | int:NADK | |
| Interaction | MAST3 interactions | 1.41e-04 | 129 | 123 | 6 | int:MAST3 | |
| Interaction | SNRNP40 interactions | USP36 FLNA ZNF609 REXO4 SETX WDR36 EP400 SMARCAL1 ZNF217 POM121C CCNT2 POM121 SUGP1 | 1.41e-04 | 637 | 123 | 13 | int:SNRNP40 |
| Interaction | KPNA3 interactions | 1.43e-04 | 248 | 123 | 8 | int:KPNA3 | |
| Interaction | MYO19 interactions | 1.60e-04 | 252 | 123 | 8 | int:MYO19 | |
| Interaction | KSR1 interactions | 1.60e-04 | 132 | 123 | 6 | int:KSR1 | |
| Interaction | OSBPL6 interactions | 1.64e-04 | 84 | 123 | 5 | int:OSBPL6 | |
| Interaction | AKT3 interactions | 1.73e-04 | 85 | 123 | 5 | int:AKT3 | |
| Interaction | SLX4 interactions | USP36 NUP50 FLNA RANBP2 EP400 KIF4A BCAR1 ATXN7 MCM9 SUGP1 MLLT1 AFF4 | 2.00e-04 | 572 | 123 | 12 | int:SLX4 |
| Interaction | SRGAP2 interactions | 2.09e-04 | 197 | 123 | 7 | int:SRGAP2 | |
| Interaction | RBMY1E interactions | 2.20e-04 | 4 | 123 | 2 | int:RBMY1E | |
| Interaction | DENND4A interactions | 2.27e-04 | 90 | 123 | 5 | int:DENND4A | |
| Interaction | KIF13B interactions | 2.38e-04 | 142 | 123 | 6 | int:KIF13B | |
| Interaction | DYRK1B interactions | 2.39e-04 | 91 | 123 | 5 | int:DYRK1B | |
| Interaction | MAPKAP1 interactions | 2.76e-04 | 146 | 123 | 6 | int:MAPKAP1 | |
| Interaction | ANKRD34A interactions | 3.07e-04 | 53 | 123 | 4 | int:ANKRD34A | |
| Interaction | NAV1 interactions | 3.08e-04 | 149 | 123 | 6 | int:NAV1 | |
| Interaction | SFN interactions | SYNRG MAP1B SH2D3A SRGAP2 BCAR1 C6orf132 KSR1 TJP1 SIPA1L1 NAV1 TJP2 KIF13A TNS3 | 3.16e-04 | 692 | 123 | 13 | int:SFN |
| Interaction | TESK2 interactions | 3.21e-04 | 97 | 123 | 5 | int:TESK2 | |
| Interaction | RALGPS2 interactions | 3.30e-04 | 54 | 123 | 4 | int:RALGPS2 | |
| Interaction | PRIMPOL interactions | 3.59e-04 | 23 | 123 | 3 | int:PRIMPOL | |
| Interaction | SH3RF3 interactions | 3.80e-04 | 56 | 123 | 4 | int:SH3RF3 | |
| Interaction | DENND1A interactions | 3.87e-04 | 101 | 123 | 5 | int:DENND1A | |
| Interaction | TJP2 interactions | 3.93e-04 | 288 | 123 | 8 | int:TJP2 | |
| Interaction | CDC25C interactions | 3.94e-04 | 156 | 123 | 6 | int:CDC25C | |
| Interaction | SETMAR interactions | 4.09e-04 | 24 | 123 | 3 | int:SETMAR | |
| Interaction | STX6 interactions | SYNRG DLG5 WASHC2C ANK3 WASHC2A CEMIP2 MICALL1 EPS15L1 KIF13A VPS53 | 4.27e-04 | 448 | 123 | 10 | int:STX6 |
| Interaction | OTUD7A interactions | 4.35e-04 | 58 | 123 | 4 | int:OTUD7A | |
| Interaction | SASS6 interactions | 4.36e-04 | 159 | 123 | 6 | int:SASS6 | |
| Interaction | DCP1B interactions | 4.43e-04 | 104 | 123 | 5 | int:DCP1B | |
| Interaction | ARHGAP21 interactions | 4.43e-04 | 223 | 123 | 7 | int:ARHGAP21 | |
| Interaction | PPP1R9B interactions | FLNA CALD1 ANK3 MAP1B RASGRF1 PCLO DLGAP4 ZYX SIPA1L1 NAV1 TJP2 CNTN1 | 4.53e-04 | 626 | 123 | 12 | int:PPP1R9B |
| Interaction | NSUN5P1 interactions | 4.64e-04 | 59 | 123 | 4 | int:NSUN5P1 | |
| Interaction | ZBTB21 interactions | 4.66e-04 | 161 | 123 | 6 | int:ZBTB21 | |
| Interaction | TBC1D25 interactions | 4.95e-04 | 60 | 123 | 4 | int:TBC1D25 | |
| Interaction | XRCC6 interactions | USP36 NUP50 REXO4 WDR36 EP400 MAP1B ZMYND8 KIF4A PNRC2 PARP6 KIF9 ASXL3 SUGP1 CLEC16A AFF4 | 5.34e-04 | 928 | 123 | 15 | int:XRCC6 |
| Interaction | DYRK1A interactions | DLG5 CALD1 MAP1B TBC1D2 NUP98 POM121 SIPA1L1 TJP2 AFF1 LIMCH1 CLEC16A | 5.72e-04 | 552 | 123 | 11 | int:DYRK1A |
| Interaction | SYDE1 interactions | 5.73e-04 | 110 | 123 | 5 | int:SYDE1 | |
| Cytoband | Yq11.223 | 6.16e-06 | 93 | 126 | 5 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 2.07e-04 | 8 | 126 | 2 | chr9q12 | |
| GeneFamily | RNA binding motif containing | 7.85e-06 | 213 | 86 | 8 | 725 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 8.55e-06 | 9 | 86 | 3 | 1280 | |
| GeneFamily | SH2 domain containing | 8.57e-06 | 101 | 86 | 6 | 741 | |
| GeneFamily | Nucleoporins | 1.55e-05 | 32 | 86 | 4 | 1051 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 6.69e-05 | 46 | 86 | 4 | 622 | |
| GeneFamily | PDZ domain containing | 8.64e-05 | 152 | 86 | 6 | 1220 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.33e-04 | 4 | 86 | 2 | 1145 | |
| GeneFamily | LIM domain containing | 1.78e-04 | 59 | 86 | 4 | 1218 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 2.50e-04 | 26 | 86 | 3 | 904 | |
| GeneFamily | WASH complex | 3.31e-04 | 6 | 86 | 2 | 1331 | |
| GeneFamily | E2F transcription factors | 6.15e-04 | 8 | 86 | 2 | 982 | |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | REXO4 AHI1 WDR36 ERF SPATA31A3 RBMY1A1 SPATA31A7 RBMY1D RBMY1B RBMY1E BCAR1 CCDC7 RBMY1F MCM9 NAV1 LIMCH1 FYB1 | 8.02e-07 | 873 | 124 | 17 | M16009 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 SETX MAP1B RPS6KA3 ZMYND8 NUP98 E2F5 SRGAP2 SIPA1L1 TJP2 AFF1 MICAL3 SPIDR BCAR3 CLEC16A | 1.32e-05 | 856 | 124 | 15 | M4500 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 1.46e-05 | 166 | 124 | 7 | M6826 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 1.76e-05 | 33 | 124 | 4 | MM701 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CPEB2 SLC4A8 ANK3 MAP1B PCLO SLITRK4 ZMYND8 CPEB3 SHROOM2 FMNL2 CHRM5 ASXL3 NAV1 MICAL3 KIF13A VPS53 CNTN1 | 1.85e-05 | 1106 | 124 | 17 | M39071 |
| Coexpression | GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP | 3.96e-05 | 194 | 124 | 7 | M6159 | |
| Coexpression | ZHENG_IL22_SIGNALING_DN | 6.12e-05 | 45 | 124 | 4 | MM763 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | CPEB2 ANK3 MAP1B DLGAP4 ZMYND8 DZIP1 BCAR1 SHROOM2 FMNL2 E2F8 USP20 CCNT2 NAV1 PNRC1 MICAL3 KIF13A | 6.53e-05 | 1102 | 124 | 16 | M2369 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MAP1B ZMYND8 NUP98 SRGAP2 TJP2 AFF1 MICAL3 LIMCH1 BCAR3 CLEC16A | 7.69e-05 | 466 | 124 | 10 | M13522 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | CPEB2 ANK3 MAP1B DLGAP4 ZMYND8 DZIP1 BCAR1 SHROOM2 FMNL2 E2F8 USP20 CCNT2 NAV1 PNRC1 MICAL3 KIF13A | 8.23e-05 | 1124 | 124 | 16 | MM1070 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-07 | 179 | 123 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.39e-07 | 188 | 123 | 7 | 6f53bcd4caab2fc961af799039ea5c3ddae56781 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-06 | 190 | 123 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-06 | 190 | 123 | 7 | d4f954e0748898df69e1710df558564db703dd61 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 1.08e-06 | 192 | 123 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 1.08e-06 | 192 | 123 | 7 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | Healthy-B_naive|Healthy / disease group, cell group and cell class | 1.08e-06 | 192 | 123 | 7 | 5fddf679dcc9c0077d6bfe04c1e602863fb959eb | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-06 | 193 | 123 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 1.16e-06 | 194 | 123 | 7 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 1.16e-06 | 194 | 123 | 7 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-06 | 195 | 123 | 7 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-06 | 195 | 123 | 7 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 1.20e-06 | 195 | 123 | 7 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 199 | 123 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-06 | 200 | 123 | 7 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-06 | 200 | 123 | 7 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 123 | 7 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.42e-06 | 200 | 123 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-06 | 200 | 123 | 7 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-06 | 200 | 123 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.55e-06 | 160 | 123 | 6 | 8396afbc7d919ba190863d50aa0ef8b9942a9866 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.09e-06 | 167 | 123 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.85e-06 | 170 | 123 | 6 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.85e-06 | 170 | 123 | 6 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.97e-06 | 174 | 123 | 6 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 9.89e-06 | 177 | 123 | 6 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.05e-05 | 179 | 123 | 6 | 5be883d7d0be3180bb9844e4a757f0dd247294e4 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-05 | 179 | 123 | 6 | 31411780f1a44bf2d102f288416e97eacec4b6b6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Micro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-05 | 184 | 123 | 6 | 371c1927ac06b77ff462a94cca6acb802f9724ff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-05 | 184 | 123 | 6 | fbac70333e4f028bfbdd9cc9401427caac9f0c47 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-05 | 184 | 123 | 6 | dd6777a0cb49cd79fc439920c3c930a1e4681bb0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 185 | 123 | 6 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 1.31e-05 | 186 | 123 | 6 | 5624b1fc7eab9f505588fcc86a24d14f8bcbfef7 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-05 | 186 | 123 | 6 | aa576748921a318798b911a611f05319b95e8d5e | |
| ToppCell | BL-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.31e-05 | 186 | 123 | 6 | 27d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 187 | 123 | 6 | 17a37fc3a1d62fef3137e5ff26a84c0b8c80e124 | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 1.35e-05 | 187 | 123 | 6 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 187 | 123 | 6 | 1b0eb29394040555516677b9de75c15e769c4c53 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 187 | 123 | 6 | 11c773cf3dc1e725b7e4d8edd676c8a94a231d2a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 187 | 123 | 6 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-05 | 188 | 123 | 6 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.43e-05 | 189 | 123 | 6 | ef33cc03728a78423ee92d2ef1ffed4918d4221f | |
| ToppCell | Healthy-B_naive|World / disease group, cell group and cell class | 1.43e-05 | 189 | 123 | 6 | 1e533a43f739ff295740cf2b25479756dfb8e595 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-05 | 189 | 123 | 6 | 389ccb68acb82893709f256315111470cf4beed3 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.43e-05 | 189 | 123 | 6 | b0244a9d1b5c8ad4708750b691184f3491b13900 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-05 | 189 | 123 | 6 | 58465b9407fbce91cca8f199950d6e0054c38fbc | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-05 | 189 | 123 | 6 | 7ac78441a15a82218deaafd47accff2ea5c8de20 | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 1.52e-05 | 191 | 123 | 6 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-05 | 191 | 123 | 6 | 5a9a592875fbd0b1429b48db29a760fdc9c2c856 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 1.62e-05 | 193 | 123 | 6 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 1.62e-05 | 193 | 123 | 6 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 194 | 123 | 6 | 96f16bcd393a0d3f8df479b172b5360ae5a1e663 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-05 | 194 | 123 | 6 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.66e-05 | 194 | 123 | 6 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.66e-05 | 194 | 123 | 6 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-05 | 194 | 123 | 6 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | COVID-19_Moderate-B_naive|World / disease group, cell group and cell class | 1.66e-05 | 194 | 123 | 6 | 1f81d618799e482a36dce528bba70f52cc69a901 | |
| ToppCell | Healthy-B_intermediate|Healthy / disease group, cell group and cell class | 1.66e-05 | 194 | 123 | 6 | aabee48bf689367edae2079b4b90d253715f1097 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 195 | 123 | 6 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-05 | 195 | 123 | 6 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | Healthy-B_intermediate|World / disease group, cell group and cell class | 1.71e-05 | 195 | 123 | 6 | 9de79e0bdd9063ae65e5edb89cc3fe6f9a8173bc | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.76e-05 | 196 | 123 | 6 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-05 | 196 | 123 | 6 | de43dd0697e1daf4d50800957cf0b27b54a7a333 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-05 | 196 | 123 | 6 | e54c08f88779f9fd453a4f5b85aed1f460d8a1e1 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-05 | 197 | 123 | 6 | f7a8440d2b8b17d9726c6fe3dd383effbfebab13 | |
| ToppCell | COVID-19_Mild-Lymphoid_B|COVID-19_Mild / Disease group, lineage and cell class | 1.81e-05 | 197 | 123 | 6 | ff25c0e184bd0f068014bc3f5eba3aee17511b87 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.81e-05 | 197 | 123 | 6 | 7cae4f3eabfebce101de7bb7defb17d6c5360b58 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-05 | 198 | 123 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.92e-05 | 199 | 123 | 6 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 1.92e-05 | 199 | 123 | 6 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid-Microglia|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-05 | 199 | 123 | 6 | 4ddfbcaa8054b69b3398d8c0d5fab8ae94805cb9 | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 1.92e-05 | 199 | 123 | 6 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-05 | 199 | 123 | 6 | 3ba48a4715d5e9387650aa97e0c5d7f7897bf380 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.97e-05 | 200 | 123 | 6 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.97e-05 | 200 | 123 | 6 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.97e-05 | 200 | 123 | 6 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.97e-05 | 200 | 123 | 6 | 19055194a5e0ea122f1b8fc62df44813f6843c95 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.97e-05 | 200 | 123 | 6 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | mild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.97e-05 | 200 | 123 | 6 | 222789b897e2a683bbfd1d00b6fd8705015d90df | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.97e-05 | 200 | 123 | 6 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.97e-05 | 200 | 123 | 6 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Control-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients | 4.08e-05 | 138 | 123 | 5 | b7920c9a28d28220e7e4b30cd91ba13d0548eb76 | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.00e-05 | 144 | 123 | 5 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(Cd4+_Tnaive-Tcm)|Lymphoid / shred on cell class and cell subclass (v4) | 6.66e-05 | 153 | 123 | 5 | ffb8ac88513e83d3ba01574e60beb5476154372b | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.87e-05 | 154 | 123 | 5 | 44d4d99b08216c0901e3bc32743fa0a8b85b5149 | |
| ToppCell | CV-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 6.87e-05 | 154 | 123 | 5 | 26bf81a86700db7e65c2384ffe94ed4253ea4047 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.09e-05 | 155 | 123 | 5 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.76e-05 | 158 | 123 | 5 | 0559cc032d0b518bb9e55aa3495f5573bd8e87dd | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.89e-05 | 82 | 123 | 4 | 89aff8676f98e062d0e69b38c7184e51aa1a915e | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.89e-05 | 82 | 123 | 4 | 6875a10abf1221b3dfd954c319b5e8e12fac1ff2 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.89e-05 | 82 | 123 | 4 | 259bb4ae0373d8352cb1c3bff08f66b89a298440 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.99e-05 | 159 | 123 | 5 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 8.23e-05 | 160 | 123 | 5 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.48e-05 | 161 | 123 | 5 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 1.04e-04 | 168 | 123 | 5 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 169 | 123 | 5 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 169 | 123 | 5 | 0425d2580ed325178f522c0093ff4623de6ce7a8 | |
| Drug | hydantoin-5-propionic acid | 7.11e-08 | 21 | 120 | 5 | CID000000782 | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.08e-06 | 198 | 120 | 9 | 5242_DN | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 5.83e-06 | 183 | 120 | 8 | 7062_DN | |
| Drug | HgCl | 5.92e-06 | 49 | 120 | 5 | CID000024182 | |
| Drug | AZFd | 6.01e-06 | 23 | 120 | 4 | CID000196489 | |
| Drug | Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.00e-05 | 197 | 120 | 8 | 7484_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.08e-05 | 199 | 120 | 8 | 7367_UP | |
| Drug | Nifurtimox [23256-30-6]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.12e-05 | 200 | 120 | 8 | 4953_UP | |
| Drug | Vistar | 3.79e-05 | 36 | 120 | 4 | CID000040896 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 3.89e-05 | 174 | 120 | 7 | 7530_DN | |
| Drug | dimethylthioarsinic acid | 3.93e-05 | 13 | 120 | 3 | ctd:C547156 | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 5.17e-05 | 182 | 120 | 7 | 3630_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.54e-05 | 184 | 120 | 7 | 2321_DN | |
| Drug | 2-chlorodideoxyadenosine | 7.73e-05 | 43 | 120 | 4 | CID000072194 | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 7.73e-05 | 194 | 120 | 7 | 4082_UP | |
| Drug | Loxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 7.73e-05 | 194 | 120 | 7 | 5293_UP | |
| Drug | Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 3737_DN | |
| Drug | Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 3254_DN | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; HL60; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 1834_UP | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; HL60; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 2207_UP | |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 2763_DN | |
| Drug | clozapine; Up 200; 10uM; HL60; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 2689_UP | |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; PC3; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 7069_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 4729_UP | |
| Drug | Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; HL60; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 2934_UP | |
| Drug | Norethynodrel [68-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 7471_UP | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; PC3; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 6289_UP | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 7280_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 7391_UP | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 6275_UP | |
| Drug | Benzthiazide [91-33-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 4952_UP | |
| Drug | Proxyphylline [603-00-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 5993_UP | |
| Drug | Adrenosterone [382-45-6]; Down 200; 13.4uM; HL60; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 3107_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; PC3; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 3713_UP | |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; PC3; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 6582_UP | |
| Drug | Diflunisal [22494-42-4]; Down 200; 16uM; MCF7; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 4794_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 5304_UP | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; HL60; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 2334_DN | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; HL60; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 2179_UP | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; PC3; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 4539_UP | |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; PC3; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 4297_UP | |
| Drug | ara-AC | 1.18e-04 | 279 | 120 | 8 | CID000001805 | |
| Drug | PKI166 | 1.19e-04 | 48 | 120 | 4 | CID006918403 | |
| Drug | bromfenacoum | NUP50 SYNRG ANK3 MAP1B NUP98 CPEB3 ZYX PPM1H NDUFV3 TJP1 LIMCH1 CNTN1 | 1.55e-04 | 644 | 120 | 12 | ctd:C013418 |
| Drug | azafagomine | 2.34e-04 | 57 | 120 | 4 | CID011957435 | |
| Drug | 2-oyl | 2.37e-04 | 105 | 120 | 5 | CID000657137 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.78e-04 | 169 | 120 | 6 | 5231_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.25e-04 | 174 | 120 | 6 | 5745_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.35e-04 | 175 | 120 | 6 | 6316_DN | |
| Drug | staurosporine; Up 200; 0.1uM; MCF7; HG-U133A | 3.46e-04 | 176 | 120 | 6 | 423_UP | |
| Drug | staurosporine; Down 200; 1uM; MCF7; HG-U133A | 4.01e-04 | 181 | 120 | 6 | 312_DN | |
| Drug | Mitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 4.13e-04 | 182 | 120 | 6 | 5354_DN | |
| Drug | thioglycolate | 4.35e-04 | 67 | 120 | 4 | CID000001133 | |
| Drug | clotrimazole; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 4.50e-04 | 185 | 120 | 6 | 905_UP | |
| Drug | lomustine; Up 200; 100uM; MCF7; HT_HG-U133A | 4.50e-04 | 185 | 120 | 6 | 7045_UP | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.77e-04 | 187 | 120 | 6 | 972_DN | |
| Drug | Gossypol [303-45-7]; Up 200; 7.8uM; PC3; HT_HG-U133A | 4.90e-04 | 188 | 120 | 6 | 4296_UP | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A | 5.04e-04 | 189 | 120 | 6 | 5936_DN | |
| Drug | SU6668 | 5.14e-04 | 70 | 120 | 4 | CID000206042 | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 5.19e-04 | 190 | 120 | 6 | 2869_DN | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 5.33e-04 | 191 | 120 | 6 | 4168_DN | |
| Drug | daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A | 5.33e-04 | 191 | 120 | 6 | 7507_DN | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; HL60; HT_HG-U133A | 5.48e-04 | 192 | 120 | 6 | 1847_DN | |
| Drug | SC 19220; Down 200; 10uM; PC3; HT_HG-U133A | 5.48e-04 | 192 | 120 | 6 | 7065_DN | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; PC3; HT_HG-U133A | 5.48e-04 | 192 | 120 | 6 | 6659_DN | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A | 5.63e-04 | 193 | 120 | 6 | 7147_UP | |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A | 5.63e-04 | 193 | 120 | 6 | 7059_DN | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; PC3; HT_HG-U133A | 5.63e-04 | 193 | 120 | 6 | 4276_UP | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 5.63e-04 | 193 | 120 | 6 | 3229_DN | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; PC3; HT_HG-U133A | 5.63e-04 | 193 | 120 | 6 | 4226_DN | |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 5.63e-04 | 193 | 120 | 6 | 5315_UP | |
| Drug | clay | 5.69e-04 | 7 | 120 | 2 | ctd:C011730 | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; HL60; HT_HG-U133A | 5.79e-04 | 194 | 120 | 6 | 2180_UP | |
| Drug | Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 5.79e-04 | 194 | 120 | 6 | 4110_UP | |
| Drug | Thonzonium bromide [553-08-2]; Down 200; 6.8uM; PC3; HT_HG-U133A | 5.79e-04 | 194 | 120 | 6 | 4617_DN | |
| Drug | Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 5.79e-04 | 194 | 120 | 6 | 7164_UP | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; HL60; HT_HG-U133A | 5.79e-04 | 194 | 120 | 6 | 2711_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 5.79e-04 | 194 | 120 | 6 | 7000_UP | |
| Drug | Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; HL60; HG-U133A | 5.79e-04 | 194 | 120 | 6 | 1599_UP | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; PC3; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 2096_UP | |
| Drug | Dubinidine [22964-77-8]; Down 200; 14.6uM; HL60; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 6131_DN | |
| Drug | Bisoprolol fumarate; Up 200; 9uM; MCF7; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 5348_UP | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; PC3; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 4070_UP | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; HL60; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 2940_UP | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; HL60; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 1292_UP | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 2727_DN | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 3135_DN | |
| Drug | Thiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 7033_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 1532_DN | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 2266_DN | |
| Drug | Hecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 3457_DN | |
| Drug | Ethionamide [536-33-4]; Up 200; 24uM; PC3; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 4593_UP | |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; PC3; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 6557_UP | |
| Drug | deferoxamine mesylate salt; Down 200; 100uM; MCF7; HG-U133A | 5.95e-04 | 195 | 120 | 6 | 573_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 4124_UP | |
| Drug | Spaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 2962_DN | |
| Drug | Solanine alpha [20562-02-1]; Up 200; 4.6uM; HL60; HT_HG-U133A | 5.95e-04 | 195 | 120 | 6 | 2152_UP | |
| Drug | Phe-gly | 6.03e-04 | 73 | 120 | 4 | CID000098207 | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 1uM; PC3; HT_HG-U133A | 6.11e-04 | 196 | 120 | 6 | 3827_UP | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; HL60; HG-U133A | 6.11e-04 | 196 | 120 | 6 | 1558_DN | |
| Disease | Malignant neoplasm of breast | FLNA RPS6KA3 SMARCAL1 RPS6KB2 SH2D3A NUP98 BCAR1 SHROOM2 METTL6 MICALL1 SIPA1L1 AFF1 DLEC1 BCAR3 | 7.68e-05 | 1074 | 115 | 14 | C0006142 |
| Disease | Immunoglobulin A deficiency (disorder) | 8.99e-05 | 4 | 115 | 2 | C0162538 | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 2.24e-04 | 6 | 115 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | colorectal adenoma | 2.89e-04 | 33 | 115 | 3 | EFO_0005406 | |
| Disease | Periventricular Nodular Heterotopia | 3.12e-04 | 7 | 115 | 2 | C1868720 | |
| Disease | response to statin, low density lipoprotein cholesterol measurement | 4.15e-04 | 8 | 115 | 2 | EFO_0004611, GO_0036273 | |
| Disease | mitral valve prolapse (is_implicated_in) | 5.32e-04 | 9 | 115 | 2 | DOID:988 (is_implicated_in) | |
| Disease | total lipids in very small VLDL measurement | 7.26e-04 | 45 | 115 | 3 | EFO_0022156 | |
| Disease | serum gamma-glutamyl transferase measurement | DLG5 SLC4A8 CALD1 RPS6KA3 SNX17 POM121C ZYX POM121 TJP1 AFF1 MICAL3 | 9.03e-04 | 914 | 115 | 11 | EFO_0004532 |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 9.20e-04 | 110 | 115 | 4 | EFO_0003095, MONDO_0005148 | |
| Disease | craniosynostosis (is_implicated_in) | 9.69e-04 | 12 | 115 | 2 | DOID:2340 (is_implicated_in) | |
| Disease | phospholipids in very small VLDL measurement | 1.05e-03 | 51 | 115 | 3 | EFO_0022300 | |
| Disease | mean corpuscular hemoglobin concentration | NUP50 WASHC2C EP400 RPS6KB2 DLGAP4 ZNF217 PPM1H E2F8 SLC14A1 AFF1 KIF4B TNS3 | 1.28e-03 | 1105 | 115 | 12 | EFO_0004528 |
| Disease | nodular sclerosis Hodgkin lymphoma | 1.33e-03 | 14 | 115 | 2 | EFO_0004708 | |
| Disease | anemia (implicated_via_orthology) | 1.53e-03 | 15 | 115 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Eczema, allergic rhinitis | 1.57e-03 | 215 | 115 | 5 | EFO_0005854, HP_0000964 | |
| Disease | Pontoneocerebellar hypoplasia | 1.74e-03 | 16 | 115 | 2 | cv:C1261175 | |
| Disease | allergic rhinitis | 1.85e-03 | 133 | 115 | 4 | EFO_0005854 | |
| Disease | total blood protein measurement | 1.93e-03 | 449 | 115 | 7 | EFO_0004536 | |
| Disease | rhinitis | 1.97e-03 | 17 | 115 | 2 | EFO_0008521 | |
| Disease | alkaline phosphatase measurement | DLG5 REXO4 SLC4A8 CALD1 RPS6KA3 SNX17 KIF9 POM121 NYNRIN SUGP1 MICAL3 | 2.07e-03 | 1015 | 115 | 11 | EFO_0004533 |
| Disease | asthma | 2.74e-03 | 751 | 115 | 9 | MONDO_0004979 | |
| Disease | platelet component distribution width | 2.83e-03 | 755 | 115 | 9 | EFO_0007984 | |
| Disease | atopic eczema | 3.13e-03 | 252 | 115 | 5 | EFO_0000274 | |
| Disease | unipolar depression, bipolar disorder | 3.30e-03 | 156 | 115 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | triacylglycerol 48:2 measurement | 3.31e-03 | 22 | 115 | 2 | EFO_0010405 | |
| Disease | alcohol consumption measurement | DLG5 SLC4A8 PCLO SNX17 FMNL2 MICALL1 C4orf17 TTLL6 MICAL3 BCAR3 CLEC16A AFF4 | 3.35e-03 | 1242 | 115 | 12 | EFO_0007878 |
| Disease | asthma, allergic disease | 3.68e-03 | 79 | 115 | 3 | MONDO_0004979, MONDO_0005271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PARAFPPSKSCVTKP | 356 | P30926 | |
| SSSPFKFKLQPPPLG | 371 | P50548 | |
| PFTSDPFTKNPSLPS | 686 | Q9UBC2 | |
| PFTKNPSLPSKLDPF | 691 | Q9UBC2 | |
| PFAKPLPTFAKPTAE | 2346 | Q96L91 | |
| FQKPSTSAFPAPVPL | 301 | O60583 | |
| TPSKFPTKVINLSPF | 1281 | Q96M83 | |
| PPTVFKDNPVSTPKD | 756 | Q9UKQ2 | |
| PAFAKAKPFDPARTP | 331 | P56945 | |
| PPTKPRSPLSVVEAF | 501 | Q8N157 | |
| KPCKVPFLKVPSSPS | 406 | O75815 | |
| PPPDLATSPTKSPFK | 251 | O95841 | |
| ATSPTKSPFKIPPVT | 256 | O95841 | |
| PVPKEEPSPATKFQS | 676 | Q9Y2H0 | |
| PPFIIKSQPVSKPES | 1021 | Q9C0F0 | |
| TPCKTEPSKFPFPTK | 336 | Q9UHB7 | |
| KPVSSPFPTKPLEGQ | 311 | Q9UKX7 | |
| PPPKKSAPSAVARSN | 161 | P0DJD3 | |
| PPPKKSAPSAVARSN | 161 | A6NDE4 | |
| PPPKKSAPSAVARSN | 161 | P0DJD4 | |
| PPPKKSAPSAVARSN | 161 | P0C7P1 | |
| PPPKKSAPSAVARSN | 161 | A6NEQ0 | |
| PPPKKSAPSAVARSN | 161 | Q15415 | |
| KPSPSTSVPAPASFK | 1571 | P49792 | |
| TVPGTPPPKKFRSLF | 351 | Q99638 | |
| FPPPSKQSLLFCPKS | 16 | Q56VL3 | |
| ISKPSEFPIKSPAFT | 136 | Q17RG1 | |
| PNPVAVKPLTESPFK | 1181 | P52948 | |
| PSFPTPAFRPVSLKS | 1351 | Q7RTP6 | |
| PPDFSPKTAKSRTPV | 1621 | P46821 | |
| FSTLPKPKPQLSRSF | 211 | Q8NCT3 | |
| FFPESKIPCPKVSRP | 2286 | Q6PRD1 | |
| FTAKTPKDSPGIPPS | 361 | P51812 | |
| KPSQSFPPTGEKVSP | 801 | Q9Y6V0 | |
| GAKFSDPPSPSVLPK | 281 | Q12796 | |
| AKFSEPPSPSVLPKP | 96 | Q9NPJ4 | |
| PPSRKVFQLLPSFPT | 291 | Q8IVT5 | |
| SGTPPARFPKAPSKL | 306 | O15117 | |
| TPPKPPRRSDSIKFQ | 1011 | Q8TDM6 | |
| SDPSLPRIPKASAKF | 1816 | P09848 | |
| KENPFNRKPSPAASP | 631 | Q8N3F8 | |
| TSVKKTFSTPSPPPV | 1531 | P98088 | |
| PDTPPSKPVAFEEFK | 571 | Q9HAQ2 | |
| ESKPFVASKPKPHTP | 436 | O15265 | |
| FLQSKFLKPPKNPSP | 261 | Q8TCB7 | |
| VPLPAPFFKQTTTPA | 761 | A8CG34 | |
| PAPFFKQTTTPATAP | 371 | A6NF01 | |
| IFTAPPKSEKEGPTP | 731 | Q96HA1 | |
| PASVPLPAPFFKQTT | 781 | Q96HA1 | |
| PKSFSSPPSPSNKRE | 961 | Q5T0Z8 | |
| PKTSPALPRDKVSPF | 1236 | Q6WRI0 | |
| PSTRFLKVPVPESPA | 146 | A4D1S0 | |
| QRHSPPFSKTLPSKP | 126 | Q8WV28 | |
| QPKPFHSVPSQPKSS | 956 | Q9BX69 | |
| KESSSSKPVVFPVPP | 231 | Q15329 | |
| LETSAFPPSKPKSPR | 181 | Q5T8R8 | |
| QPDFGPLTTPTKPKE | 36 | A0AVK6 | |
| STKPLLAPKPQGPAF | 416 | Q99704 | |
| APPKFTRSTPSLTPK | 176 | Q7Z5Q1 | |
| PLKKPFSSNVIAPPK | 291 | Q8NE35 | |
| PFPLEAVAPTKPSKV | 1056 | P21333 | |
| KPSPKPTFGPDSVEH | 26 | Q8NCU4 | |
| SPPTVKLPPNFTAKS | 251 | Q53FE4 | |
| IEAFTKKAPPSQPPR | 896 | Q12860 | |
| PIKATSPKDTFPPNH | 3866 | Q12955 | |
| RPPPPPKSQASAKFT | 36 | Q9UHN6 | |
| SAFKAPKLPPKPQFL | 346 | Q68D51 | |
| NPKTTPPSVFFPVFV | 961 | Q96PY5 | |
| VLSKKTPPAPSPFDL | 1176 | O95239 | |
| KKTAPAPSPFDLPES | 1181 | Q2VIQ3 | |
| LPTIPLSAFSDPKKT | 161 | Q03111 | |
| FPPKKPAPIGEFQST | 346 | Q9Y238 | |
| PKPFSPQLSAPITTK | 491 | Q9ULU4 | |
| PKSPEPEATLTFPFL | 716 | Q9UPQ0 | |
| APAASKAPAAPKVPV | 656 | Q9P2P1 | |
| IFSPIPKSPSFPIIQ | 176 | Q2NL67 | |
| LTVSPFKAFSPQPPK | 1451 | Q9H1H9 | |
| FCFTPPSESKSKSPP | 1061 | Q9NXL9 | |
| PPTPLRATAKSFVKP | 781 | Q8NEY1 | |
| VPASKRAPSSPVAKP | 6 | Q9GZR2 | |
| PKLLNKPSAPFTSPA | 581 | Q8IW52 | |
| KPSAPFTSPAPAITF | 586 | Q8IW52 | |
| AFAQKTRPIKPPPDS | 536 | A4FU49 | |
| PLEPPTKDKTFPPSF | 581 | Q9UMZ2 | |
| SSPRAPVSPLKFSPF | 416 | Q9UBS0 | |
| EFSLSQPPKSPNKSP | 566 | Q8NE09 | |
| LPSKKQPPSVSPFGE | 1151 | Q8IWB4 | |
| TPRSPQPELSTFPKK | 201 | Q96QH2 | |
| FTPFANPTHKPLAKP | 156 | Q9NZC9 | |
| PPIPKGVTFPKSNVF | 766 | O43166 | |
| GQPPISPKKFLPSTA | 966 | Q92835 | |
| SSFPKPAPRKDQESP | 1026 | Q92835 | |
| PPASKPLRPTTKIFS | 1586 | Q7Z333 | |
| SPSPQFAPQKLTDKP | 1171 | Q13796 | |
| PSPKLQVPSVFKPTR | 751 | Q2Y0W8 | |
| TQQPSPSKAFKPRFP | 656 | Q68CZ2 | |
| EPPKSPRATRKFSSP | 726 | Q13972 | |
| DPFPRKSSTITTPPF | 666 | Q86YF9 | |
| PFPVAKEPSTKGLNP | 406 | P08912 | |
| SAKPTKPAASDLPVP | 691 | Q05682 | |
| TPSTAEPSKFPFPTK | 376 | P51825 | |
| KPASSPHSKPFPILQ | 776 | Q2KHT3 | |
| SFTAPDPGLKRKSPP | 326 | Q8IWZ8 | |
| LPSKKQPPSVSPFGE | 1151 | Q5VYP0 | |
| LPAFPPKKLFSLTPA | 56 | Q15036 | |
| AKPTFGRSILKPSTP | 1041 | Q9UDY2 | |
| LPSKKQPPSVSPFGE | 1151 | Q5VU36 | |
| SPSTPPTRFFTEKKI | 221 | Q9ULR3 | |
| HTPQKPTAKFPRTPE | 236 | Q14159 | |
| QAKAPTKPPRTPSFE | 206 | Q9BRG2 | |
| PKPTVFPKTNATSPG | 1041 | O75044 | |
| KKTLFPPQPQSKDSP | 876 | O15014 | |
| VVPDKAASPRSSPKP | 176 | A6NKC9 | |
| LFGSPPTSVPPATKK | 701 | Q9Y4E1 | |
| NSKTPIFSPFPSVKP | 866 | Q9Y2I9 | |
| QPFFPSCSVPKLPKK | 121 | Q8TCU3 | |
| VFPKLTSAKPFSSLP | 581 | Q8N841 | |
| PFFPAKLVIPITTAP | 196 | Q13336 | |
| TLKKLESPPPSTNPF | 371 | Q5VIR6 | |
| KFSEQDSPPPSHPLK | 106 | Q9Y2K6 | |
| SPPLSADSFKPFRSP | 146 | Q6ZNC4 | |
| FKPPEVASKPSGAPI | 1291 | Q07157 | |
| LFGSPPTSVPPATKK | 701 | Q641Q2 | |
| APAPKFSPVTPKFTP | 261 | Q15942 | |
| PKFTPVASKFSPGAP | 271 | Q15942 | |
| PPLSSFCKPKPKSAF | 766 | O75362 | |
| PKLIVPSEFKPTSPN | 751 | Q9Y6R1 | |
| SVIPPPKFAVVFSPI | 1686 | A6NGW2 | |
| VKKPAPPQHFSPRTA | 536 | Q9P275 | |
| DSPKPAPKPSLTISF | 266 | Q9BYX2 | |
| PKVPKSAPFFIPTIP | 781 | Q8NI36 | |
| KGPPKVPFRSKPTSA | 791 | Q8N5Q1 | |
| KKPAPVPAEPFDNTT | 56 | P56181 |